Magnetic resonance and diffusion tensor imaging in pediatric white matter diseases

Topics in Magnetic Resonance Imaging

Volumn 17, Issue 4, 2006, Pages 265-274

  Kim, Michael J J ^a   Provenzale, James M ^b   Law, Meng ^c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Diffusion tensor imaging; Leukoencephalopathies; Magnetic resonance imaging; Pediatric; White matter diseases

Indexed keywords

ADOLESCENCE; ADRENOLEUKODYSTROPHY; BONE MARROW TRANSPLANTATION; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN DISEASE; BRAIN MATURATION; CENTRAL NERVOUS SYSTEM; CHILDHOOD; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DIFFUSION TENSOR IMAGING; GLOBOID CELL LEUKODYSTROPHY; HOLOPROSENCEPHALY; HUMAN; LEUKOENCEPHALOPATHY; MITOCHONDRIAL ENCEPHALOMYOPATHY; NERVE CELL DIFFERENTIATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PERINATAL PERIOD; PHENYLKETONURIA; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVIEW; SENSITIVITY AND SPECIFICITY; STEM CELL TRANSPLANTATION; WHITE MATTER;

ADOLESCENT; BRAIN; BRAIN DISEASES; CHILD; CHILD, PRESCHOOL; DEMYELINATING DISEASES; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; INFANT; INFANT, NEWBORN; NERVE FIBERS, MYELINATED;

EID: 34247099254     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rmr.0000248665.84211.0f     Document Type: Review

References (91)

1. Basser PJ. Inferring microstructural features and the physiological state of tissues from diffusion-weighted images. NMR Biomed. 1995;8:333-344.
2. Wimberger DM, Roberts TP, Barkovich AJ, et al. Identification of "premyelination" by diffusion-weighted MRI. J Comput Assist Tomogr. 1995;19:28-33.
3. Suzuki K. Globoid cell leukodystrophy (Krabbe's disease): update. J Child Neurol. 2003;18:595-603.
4. Loes DJ, Peters C, Krivit W. Globoid cell leukodystrophy: distinguishing early-onset from late-onset disease using a brain MR imaging scoring method. AJNR Am J Neuroradiol. 1999;20:316-323.
5. Krivit W, Shapiro EG, Peters C, et al. Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N Engl J Med. 1998;338:1119-1126.
6. Barkovich AJ. Concepts of myelin and myelination in neuroradiology. AJNR Am J Neuroradiol. 2000;21:1099-1109.
7. Guo AC, Petrella JR, Kurtzberg J, et al. Evaluation of white matter anisotropy in Krabbe disease with diffusion tensor MR imaging: initial experience. Radiology. 2001;218:809-815.
8. Barone R, Bruhl K, Stoeter P, et al. Clinical and neuroradiological findings in classic infantile and late-onset globoid-cell leukodystrophy (Krabbe disease). Am J Med Genet. 1996;63:209-217.
9. Sasaki M, Sakuragawa N, Takashima S, et al. MRI and CT findings in Krabbe disease. Pediatr Neurol. 1991;7:283-288.
10. Finelli DA, Tarr RW, Sawyer RN, et al. Deceptively normal MR in early infantile Krabbe disease. AJNR Am J Neuroradiol. 1994;15:167-171.
11. Zafeiriou DI, Michelakaki EM, Anastasiou AL, et al. Serial MRI and neurophysiological studies in late-infantile Krabbe disease. Pediatr Neurol. 1996;15:240-244.
12. Powers JM, Rubio A. Selected leukodystrophies. Semin Pediatr Neurol. 1995;2:200-210.
13. McGraw P, Liang L, Escolar M, et al. Krabbe disease treated with hematopoietic stem cell transplantation: serial assessment of anisotropy measurements - initial experience. Radiology. 2005;236:221-230.
14. Escolar ML, Poe MD, Provenzale JM, et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med. 2005;352:2069-2081.
15. Moser HW, Loes DJ, Melhem ER, et al. X-linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients. Neuropediatrics. 2000;31:227-239.
16. Mosser J, Lutz Y, Stoeckel ME, et al. The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. Hum Mol Genet. 1994;3:265-271.
17. Mosser J, Douar AM, Sarde CO, et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature. 1993;361:726-730.
18. Igarashi M, Schaumburg HH, Powers J, et al. Fatty acid abnormality in adrenoleukodystrophy. J Neurochem. 1976;26:851-860.
19. Powers JM. Adreno-leukodystrophy (adreno-testiculo-leukomyeloneuropathic- complex). Clin Neuropathol. 1985;4:181-199.
20. Percy AK, Rutledge SL. Adrenoleukodystrophy and related disorders. Ment Retard Dev Disabil Res Rev. 2001;7:179-189.
21. Suzuki Y, Isogai K, Teramoto T, et al. Bone marrow transplantation for the treatment of X-linked adrenoleukodystrophy. J Inherit Metab Dis. 2000;23:453-458.
22. Loes DJ, Hite S, Moser H, et al. Adrenoleukodystrophy: a scoring method for brain MR observations. AJNR Am J Neuroradiol. 1994;15:1761-1766.
23. Kruse B, Barker PB, van Zijl PC, et al. Multislice proton magnetic resonance spectroscopic imaging in X-linked adrenoleukodystrophy. Ann Neurol. 1994;36:595-608.
24. Eichler FS, Itoh R, Barker PB, et al. Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience. Radiology. 2002;225:245-252.
25. Simon EM, Barkovich AJ. Holoprosencephaly: new concepts. Magn Reson Imaging Clin N Am. 2001;9:149-164, viii-vix.
26. DeMeyer W, Zeman W, Palmer CG. The face predicts the brain: diagnostic significance of median facial anomalies for holoprosencephaly (arhinencephaly). Pediatrics. 1964;34:256-263.
27. Roessler E, Belloni E, Gaudenz K, et al. Mutations in the human sonic hedgehog gene cause holoprosencephaly. Nat Genet. 1996;14:357-360.
28. Albayram S, Melhem ER, Mori S, et al. Holoprosencephaly in children: diffusion tensor MR imaging of white matter tracts of the brainstem - initial experience. Radiology. 2002;223:645-651.
29. Kinsman SL. White matter imaging in holoprosencephaly in children. Curr Opin Neurol. 2004;17:115-119.
30. Scriver CR. Science, medicine and phenylketonuria. Acta Paediatr Suppl. 1994;407:11-18.
31. Pietz J, Meyding-Lamade UK, Schmidt H. Magnetic resonance imaging of the brain in adolescents with phenylketonuria and in one case of 6-pyruvoyl tetrahydropteridine synthase deficiency. Eur J Pediatr. 1996;155(suppl 1):69-73.
32. Ushakova GA, Gubkina HA, Kachur VA, et al. Effect of experimental hyperphenylalaninemia on the postnatal rat brain. Int J Dev Neurosci. 1997;15:29-36.
33. Kienzle Hagen ME, Pederzolli CD, Sgaravatti AM, et al. Experimental hyperphenylalaninemia provokes oxidative stress in rat brain. Biochim Biophys Acta. 2002;1586:344-352.
34. Infante JP, Huszagh VA. Impaired arachidonic (20:4n-6) and docosahexaenoic (22:6n-3) acid synthesis by phenylalanine metabolites as etiological factors in the neuropathology of phenylketonuria. Mol Genet Metab. 2001;72:185-198.
35. Malamud N. Neuropathology of phenylketonuria. J Neuropathol Exp Neurol. 1966;25:254-268.
36. Poser CM, Van Bogaert L. Neuro-pathologic observations in phenylketonuria. Brain. 1959;82:1-9.
37. Sugita R, Takahashi S, Ishii K, et al. Brain CT and MR findings in hyperphenylalaninemia due to dihydropteridine reductase deficiency (variant of phenylketonuria). J Comput Assist Tomogr. 1990;14:699-703.
38. Gudinchet F, Maeder P, Meuli RA, et al. Cranial CT and MRI in malignant phenylketonuria. Pediatr Radiol. 1992;22:223-224.
39. Brismar J, Aqeel A, Gascon G, et al. Malignant hyperphenylalaninemia: CT and MR of the brain. AJNR Am J Neuroradiol. 1990;11:135-138.
40. Peng SS, Tseng WY, Chien YH, et al. Diffusion tensor images in children with early-treated, chronic, malignant phenylketonuric: correlation with intelligence assessment. AJNR Am J Neuroradiol. 2004;25:1569-1574.
41. Mader I, Herrlinger U, Klose U, et al. Progressive multifocal leukoencephalopathy: analysis of lesion development with diffusion-weighted MRI. Neuroradiology. 2003;45:717-721. Epub August 27, 2003.
42. Skiest DJ. Focal neurological disease in patients with acquired immunodeficiency syndrome. Clin Infect Dis. 2002;34:103-115.
43. Whiteman ML, Post MJ, Berger JR, et al. Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology. 1993;187:233-240.
44. Post MJ, Yiannoutsos C, Simpson D, et al. AIDS Clinical Trials Group, 243 Team. Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AJNR Am J Neuroradiol. 1999;20:1896-1906.
45. Huisman TA, Boltshauser E, Martin E, et al. Diffusion tensor imaging in progressive multifocal leukoencephalopathy: early predictor for demyelination? AJNR Am J Neuroradiol. 2005;26:2153-2156.
46. Morton DH, Strauss KA, Robinson DL, et al. Diagnosis and treatment of maple syrup disease: a study of 36 patients. Pediatrics. 2002;109:999-1008.
47. Brismar J, Aqeel A, Brismar G, et al. Maple syrup urine disease: findings on CT and MR scans of the brain in 10 infants. AJNR Am J Neuroradiol. 1990;11:1219-1228.
48. Uziel G, Savoiardo M, Nardocci N. CT and MRI in maple syrup urine disease. Neurology. 1988;38:486-488.
49. Parmar H, Sitoh YY, Ho L. Maple syrup urine disease: diffusion-weighted and diffusion-tensor magnetic resonance imaging findings. J Comput Assist Tomogr. 2004;28:93-97.
50. DiMauro S, Moraes CT. Mitochondrial encephalomyopathies. Arch Neurol. 1993;50:1197-1208.
51. Ohara S, Ohama E, Takahashi H, et al. Alterations of oligodendrocytes and demyelination in the spinal cord of patients with mitochondrial encephalomyopathy. J Neurol Sci. 1988;86:19-29.
52. Sandhu FS, Dillon WP. MR demonstration of leukoencephalopathy associated with mitochondrial encephalomyopathy: case report. AJNR Am J Neuroradiol. 1991;12:375-379.
53. Neil JJ, Shiran SI, McKinstry RC, et al. Normal brain in human newborns: apparent diffusion coefficient and diffusion anisotropy measured by using diffusion tensor MR imaging. Radiology. 1998;209:57-66.
54. Partridge SC, Mukherjee P, Henry RG, et al. Diffusion tensor imaging: serial quantitation of white matter tract maturity in premature newborns. Neuroimage. 2004;22:1302-1314.
55. Shimony JS, McKinstry RC, Akbudak E, et al. Quantitative diffusion-tensor anisotropy brain MR imaging: normative human data and anatomic analysis. Radiology. 1999;212:770-784.
56. McGraw P, Liang L, Provenzale JM. Evaluation of normal age-related changes in anisotropy during infancy and childhood as shown by diffusion tensor imaging. AJR Am J Roentgenol. 2002;179:1515-1522.
57. Barkovich AJ, Kjos BO, Jackson DE Jr, et al. Normal maturation of the neonatal and infant brain: MR imaging at 1.5 T. Radiology. 1988; 166(1 Pt 1):173-180.
58. Dobbing J, Sands J. Quantitative growth and development of human brain. Arch Dis Child. 1973;48:757-767.
59. Hayakawa K, Konishi Y, Kuriyama M, et al. Normal brain maturation in MRI. Eur J Radiol. 1991;12:208-215.
60. Richardson EP Jr. Myelination in the human central nervous system. In: Haymaker W, Adams RD, eds. Histology and Histopathology of the Nervous System. Springfield, IL: Thomas; 1982:146-173.
61. van der Knaap MS, Valk J, Bakker CJ, et al. Myelination as an expression of the functional maturity of the brain. Dev Med Child Neurol. 1991;33:849-857.
62. Mukherjee P, Miller JH, Shimony JS, et al. Normal brain maturation during childhood: developmental trends characterized with diffusion-tensor MR imaging. Radiology. 2001;221:349-358.
63. Klingberg T, Vaidya CJ, Gabrieli JD, et al. Myelination and organization of the frontal white matter in children: a diffusion tensor MRI study. Neuroreport. 1999;10:2817-2821.
64. Snook L, Paulson LA, Roy D, et al. Diffusion tensor imaging of neurodevelopment in children and young adults. Neuroimage. 2005;26:1164-1173.
65. Hamilton BE, Martin JA, Ventura SJ, et al. Births: preliminary data for 2004. Natl Vital Stat Rep. 2005;54:1-17.
66. Rapin I. Autism. N Engl J Med. 1997;337:97-104. Review.
67. Schonwald A, Lechner E. Attention deficit/hyperactivity disorder: complexities and controversies. Curr Opin Pediatr. 2006;18:189-195.
68. Okumura A, Kato T, Kuno K, et al. MRI findings in patients with spastic cerebral palsy. II: Correlation with type of cerebral palsy. Dev Med Child Neurol. 1997;39:369-372.
69. Huppi PS, Murphy B, Maier SE, et al. Microstructural brain development after perinatal cerebral white matter injury assessed by diffusion tensor magnetic resonance imaging. Pediatrics. 2001;107:455-460.
70. Miller SP, Vigneron DB, Henry RG, et al. Serial quantitative diffusion tensor MRI of the premature brain: development in newborns with and without injury. J Magn Reson Imaging. 2002;16:621-632.
71. Johnston MV. Clinical disorders of brain plasticity. Brain Dev. 2004;26:73-80.
72. Nosarti C, Al-Asady MH, Frangou S, et al. Adolescents who were born very preterm have decreased brain volumes. Brain. 2002;125(Pt 7):1616-1623.
73. Stewart AL, Rifkin L, Amess PN, et al. Brain structure and neurocognitive and behavioural function in adolescents who were born very preterm. Lancet. 1999;353:1653-1657.
74. Nagy Z, Westerberg H, Skare S, et al. Preterm children have disturbances of white matter at 11 years of age as shown by diffusion tensor imaging. Pediatr Res. 2003;54:672-679.
75. Deary IJ, Bastin ME, Pattie A, et al. White matter integrity and cognition in childhood and old age. Neurology. 2006;66:505-512.
76. Edwards SG, Liu C, Blumhardt LD. Cognitive correlates of supratentorial atrophy on MRI in multiple sclerosis. Acta Neurol Scand. 2001;104:214-223.
77. Rovaris M, Iannucci G, Falautano M, et al. Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging. J Neurol Sci. 2002;195:103-109.
78. O'Sullivan M, Jones DK, Summers PE, et al. Evidence for cortical "disconnection" as a mechanism of age-related cognitive decline. Neurology. 2001;57:632-638.
79. Klingberg T, Hedehus M, Temple E, et al. Microstructure of temporo-parietal white matter as a basis for reading ability: evidence from diffusion tensor magnetic resonance imaging. Neuron. 2000;25:493-500.
80. Paus T, Collins DL, Evans AC, et al. Maturation of white matter in the human brain: a review of magnetic resonance studies. Brain Res Bull. 2001;54:255-266.
81. Huppi PS, Maier SE, Peled S, et al. Microstructural development of human newborn cerebral white matter assessed in vivo by diffusion tensor magnetic resonance imaging. Pediatr Res. 1998;44:584-590.
82. Schmithorst VJ, Wilke M, Dardzinski BJ, et al. Cognitive functions correlate with white matter architecture in a normal pediatric population: a diffusion tensor MRI study. Hum Brain Mapp. 2005;26:139-147.
83. Deary IJ, Bastin ME, Pattie A, et al. White matter integrity and cognition in childhood and old age. Neurology. 2006;66:505-512.
84. Pearsen KD, Gean-Marton AD, Levy HL, et al. Phenylketonuria: MR imaging of the brain with clinical correlation. Radiology. 1990;177:437-440.
85. Khong PL, Leung LH, Fung AS, et al. White matter anisotropy in post-treatment childhood cancer survivors: preliminary evidence of association with neurocognitive function. J Clin Oncol. 2006;24:884-890.
86. Khong PL, Kwong DL, Chan GC, et al. Diffusion-tensor imaging for the detection and quantification of treatment-induced white matter injury in children with medulloblastoma: a pilot study. AJNR Am J Neuroradiol. 2003;24:734-740.
87. Chin HW, Maruyama Y. Age at treatment and long-term performance results in medulloblastoma. Cancer. 1984;53:1952-1958.
88. Kimmings E, Kleinlugtebeld AT, Casey A, et al. Medulloblastoma: factors influencing the educational potential of surviving children. Br J Neurosurg. 1995;9:611-617.
89. Als H, Duffy FH, McAnulty GB, et al. Early experience alters brain function and structure. Pediatrics. 2004;113:846-857.
90. Westrup B, Kleberg A, Von Eichwald K, et al. A randomized, controlled trial to evaluate the effects of the newborn individualized developmental care and assessment program in a Swedish setting. Pediatrics. 2000;105(1 Pt 1):66-72.
91. Hoon AH Jr, Lawrie WT Jr, Melhem ER, et al. Diffusion tensor imaging of periventricular leukomalacia shows affected sensory cortex white matter pathways. Neurology. 2002;59:752-756.